# Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

> **NCT02438410** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 13 (actual)

## Conditions studied

- Colitis, Ulcerative
- Inflammatory Bowel Disease
- IBD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02438410
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-12-04
- **Final completion:** 2019-12-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02438410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02438410, "Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02438410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*